Netflix On Pace for Lowest Close Since August 2024 -- Data Talk
Dow Jones2026/10/21 13:36Netflix, Inc. (NFLX) is currently at $65.56, down $3.13 or 4.56%
--Would be lowest close since Aug. 13, 2024, when it closed at $64.80
--On pace for largest percent decrease since Sept. 18, 2026, when it fell 4.67%
--Currently down four consecutive days; down 9.72% over this period
--Longest losing streak since Sept. 18, 2026, when it fell for four straight trading days
--Worst four day stretch since the four days ending Sept. 18, 2026, when it fell 10.62%
--Down 5.78% month-to-date
--Down 30.08% year-to-date; on pace for worst year since 2022, when it fell 51.05%
--Down 51.05% from its all-time closing high of $133.91 on June 30, 2025
--Down 41.28% from 52 weeks ago (Oct. 22, 2025), when it closed at $111.64
--Down 43.37% from its 52-week closing high of $115.75 on Nov. 12, 2025
--Would be a new 52-week closing low
--Traded as low as $64.10; lowest intraday level since Aug. 13, 2024, when it hit $63.55
--Down 6.68% at today's intraday low; largest intraday percent decrease since Sept. 18, 2026, when it fell as much as 6.9%
--Third worst performer in the S&P 500 today
--Most active stock in the S&P 500 today
--Second worst performer in the Nasdaq 100 today
--Second most active stock in the Nasdaq 100 today
All data as of 9:34:40 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 21, 2026 09:36 ET (13:36 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
